JP2025511084A5 - - Google Patents

Info

Publication number
JP2025511084A5
JP2025511084A5 JP2024557761A JP2024557761A JP2025511084A5 JP 2025511084 A5 JP2025511084 A5 JP 2025511084A5 JP 2024557761 A JP2024557761 A JP 2024557761A JP 2024557761 A JP2024557761 A JP 2024557761A JP 2025511084 A5 JP2025511084 A5 JP 2025511084A5
Authority
JP
Japan
Application number
JP2024557761A
Other languages
Japanese (ja)
Other versions
JP2025511084A (ja
JPWO2023186798A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/057828 external-priority patent/WO2023186798A1/en
Publication of JP2025511084A publication Critical patent/JP2025511084A/ja
Publication of JPWO2023186798A5 publication Critical patent/JPWO2023186798A5/ja
Publication of JP2025511084A5 publication Critical patent/JP2025511084A5/ja
Pending legal-status Critical Current

Links

JP2024557761A 2022-03-27 2023-03-27 睡眠障害の処置に使用するための5-meo-dmt Pending JP2025511084A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP22000085.5 2022-03-27
EP22000085 2022-03-27
EP22000084.8 2022-03-27
EP22000084 2022-03-27
EP23154014.7 2023-01-30
EP23153996 2023-01-30
EP23154014 2023-01-30
EP23153996.6 2023-01-30
PCT/EP2023/057828 WO2023186798A1 (en) 2022-03-27 2023-03-27 5-meo-dmt for use in the treatment of sleep disturbance

Publications (3)

Publication Number Publication Date
JP2025511084A JP2025511084A (ja) 2025-04-15
JPWO2023186798A5 JPWO2023186798A5 (https=) 2026-04-06
JP2025511084A5 true JP2025511084A5 (https=) 2026-04-06

Family

ID=86007029

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2024557761A Pending JP2025511084A (ja) 2022-03-27 2023-03-27 睡眠障害の処置に使用するための5-meo-dmt
JP2024557206A Pending JP2025510294A (ja) 2022-03-27 2023-03-27 精神運動遅滞の治療のための5-メトキシ-n,n-ジメチルトリプタミン
JP2024557208A Pending JP2025510296A (ja) 2022-03-27 2023-03-27 認知機能不全の処置のための5-メトキシ-n,n-ジメチルトリプタミン
JP2024557199A Pending JP2025510914A (ja) 2022-03-27 2023-03-27 産後うつ病の治療
JP2024557207A Pending JP2025510295A (ja) 2022-03-27 2023-03-27 社会的/情動的引きこもりまたは離隔の処置のための5-メトキシ-n,n-ジメチルトリプタミン
JP2024557197A Pending JP2025510913A (ja) 2022-03-27 2023-03-27 双極性障害の処置のための5-MeO-DMT
JP2024557757A Pending JP2025512866A (ja) 2022-03-27 2023-03-27 不安の治療のための5-メトキシ-n,n-ジメチルトリプタミン

Family Applications After (6)

Application Number Title Priority Date Filing Date
JP2024557206A Pending JP2025510294A (ja) 2022-03-27 2023-03-27 精神運動遅滞の治療のための5-メトキシ-n,n-ジメチルトリプタミン
JP2024557208A Pending JP2025510296A (ja) 2022-03-27 2023-03-27 認知機能不全の処置のための5-メトキシ-n,n-ジメチルトリプタミン
JP2024557199A Pending JP2025510914A (ja) 2022-03-27 2023-03-27 産後うつ病の治療
JP2024557207A Pending JP2025510295A (ja) 2022-03-27 2023-03-27 社会的/情動的引きこもりまたは離隔の処置のための5-メトキシ-n,n-ジメチルトリプタミン
JP2024557197A Pending JP2025510913A (ja) 2022-03-27 2023-03-27 双極性障害の処置のための5-MeO-DMT
JP2024557757A Pending JP2025512866A (ja) 2022-03-27 2023-03-27 不安の治療のための5-メトキシ-n,n-ジメチルトリプタミン

Country Status (9)

Country Link
US (10) US20250170099A1 (https=)
EP (8) EP4499081A1 (https=)
JP (7) JP2025511084A (https=)
KR (7) KR20250005175A (https=)
CN (5) CN119546298A (https=)
AU (7) AU2023244453A1 (https=)
CA (7) CA3255654A1 (https=)
IL (7) IL315892A (https=)
WO (9) WO2023186832A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12534441B2 (en) 2021-01-15 2026-01-27 Beckley Psytech Limited Tryptamine analogues
EP4126857A1 (en) 2021-01-15 2023-02-08 Beckley Psytech Limited Ergoline analogues
US11312684B1 (en) 2021-02-10 2022-04-26 Eleusis Therapeutics Us, Inc. Pharmaceutically acceptable salts of psilocin and uses thereof
US12264131B2 (en) 2022-08-19 2025-04-01 Beckley Psytech Limited Pharmaceutically acceptable salts and compositions thereof
GB202306256D0 (en) * 2023-04-27 2023-06-14 Beckley Psytech Ltd 5-Methoxy-N,N-Dimethyltryptamine Formulations
US12246005B2 (en) 2023-06-13 2025-03-11 Beckley Psytech Limited 5-methoxy-n,n-dimethyltryptamine (5-MeO-DMT) formulations
WO2026078143A1 (en) 2024-10-09 2026-04-16 GH Research Ireland Limited Combinations of 5-meo-dmt with antidepressants for treating depression

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200147038A1 (en) * 2017-04-20 2020-05-14 Eleusis Benefit Corporation, Pbc Assessing and treating psychedelic-responsive subjects
MA50786A (fr) * 2017-10-26 2022-04-27 Blumentech S L Produit d'association pour le traitement de troubles neurologiques et/ou psychiatriques
EP4353314A3 (en) 2019-02-22 2024-07-03 GH Research Ireland Limited 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) for treating major depression
MD3927338T2 (ro) * 2019-02-22 2025-03-31 Gh Res Ireland Limited Compoziții cuprinzând 5-metoxi-N,N-dimetiltriptamină (5-MeO-DMT) pentru utilizare în tratarea tulburărilor mentale
KR20220009954A (ko) * 2019-04-17 2022-01-25 컴퍼스 패쓰파인더 리미티드 신경인지 장애, 만성 통증을 치료하고 염증을 감소시키는 방법
KR20230124103A (ko) * 2020-02-18 2023-08-24 길가메쉬 파마슈티컬스, 인코포레이티드 기분 장애 치료에 사용되기 위한 특이적 트립타민
WO2021216489A1 (en) * 2020-04-20 2021-10-28 Lobe Sciences Ltd. Methods for treating mild traumatic brain injury, post traumatic stress disorder and mild traumatic brain injury
WO2021250435A1 (en) * 2020-06-12 2021-12-16 Beckley Psytech Limited Pharmaceutical composition comprising 5-methoxy-n,n-dimethyltryptamine
US11406619B2 (en) * 2020-08-28 2022-08-09 Small Pharma Ltd Injectable formulations
WO2022189662A1 (en) * 2021-03-12 2022-09-15 Alvarius Pharmaceuticals Ltd. Compositions and methods for treating addictions comprising 5-meo-dmt
MX2023012651A (es) * 2021-04-26 2023-11-06 Atai Therapeutics Inc Novedosas composiciones y metodos de n,n-dimetiltriptamina.
US20240390301A1 (en) * 2021-08-23 2024-11-28 Gilgamesh Pharmaceuticals, Inc. Combinations of peripheral 5-ht2a receptor antagonists and central 5-ht2a receptor agonists
AU2022413759A1 (en) * 2021-12-13 2024-06-27 Beckley Psytech Limited Benzoate salt of 5-methoxy-n,n-dimethyltryptamine

Similar Documents

Publication Publication Date Title
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13150U (https=)
BY13158U (https=)
CN307050111S (https=)
BY13140U (https=)
BY13141U (https=)
BY13142U (https=)
BY13143U (https=)
BY13144U (https=)
BY13145U (https=)
BY13149U (https=)
CN307050091S (https=)